Heat Biologics (HTBX) Sees Additional Upside
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Heat Biologics (NASDAQ: HTBX) is seeing continued upside in pre-open trade. Shares are up 17.3% after gaining 30% on Friday and 25% on Wednesday (market was closed Thursday).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Herbalife (HLF) Says SEC Requested Documents on Anti-Corruption Compliance in China; Reviewed with DoJ
- Walgreens Boots Alliance (NASDAQ: WBA) puts active on U.S. not satisfied with plan for Rite Aid (RAD deal, Bloomberg reports
- Puts with increasing volatility movement and volume: WBA RAD TDG
Create E-mail Alert Related CategoriesMomentum Movers, Trader Talk
Related EntitiesPre Market Movers
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!